Quick Answer
Q32 Bio Inc. reported Total Revenue of $53.74 million for the year ending 2025.
- This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $823.4 thousand | Q1 2018: $1.13 million | Q2 2018: $1.40 million | Q3 2018: $1.60 million | Q1 2019: $270.0 thousand | Q2 2019: $392.0 thousand | Q3 2019: $441.0 thousand | Q1 2020: $588.0 thousand | Q2 2020: $567.0 thousand | Q3 2020: $567.0 thousand | Q1 2021: $29.31 million | Q2 2021: $2.19 million | Q3 2021: $1.68 million | Q1 2022: $802.0 thousand | Q2 2022: $802.0 thousand | Q3 2022: $802.0 thousand | Q1 2023: $802.0 thousand | Q1 2023: $2.95 million | Q2 2023: $354.0 thousand | Q2 2023: $3.21 million | Q3 2023: $0.00 | Q3 2023: $1.86 million | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00.
- Over the full 10 years of available data (2018 to 2025), Q32 Bio Inc.'s Total Revenue has grown by 1,358.7%.
- Historical annual values: Fiscal year 2025: $53.74 million | Fiscal year 2024: $0.00 | Fiscal year 2023: -$6.65 million | Fiscal year 2023: $1.16 million | Fiscal year 2022: $3.21 million | Fiscal year 2021: $33.97 million | Fiscal year 2020: $2.70 million | Fiscal year 2019: $1.67 million | Fiscal year 2018: $5.32 million | Fiscal year 2018: $3.68 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: